AQUINNAH PHARMACEUTICALS INC has a total of 21 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are IFM DUE INC, FRONTHERA U S PHARMACEUTICALS LLC and BIOARDIS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 6 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Vacca Joseph P | 13 |
#2 | Larsen Glenn R | 13 |
#3 | Weigele Manfred | 9 |
#4 | Burnett Duane A | 7 |
#5 | Wolozin Benjamin | 5 |
#6 | Apicco Daniel J | 4 |
#7 | Vanderweyde Tara | 4 |
#8 | Vacca Joseph | 3 |
#9 | Ripka Amy | 3 |
#10 | Burnett Duane | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020117877A1 | Compounds, compositions and methods of use | |
WO2018195075A1 | Compounds, compositions and methods of use | |
EP3557998A1 | Compouns, compositions and methods of use | |
WO2017066657A1 | Nucleic acid based tia-1 inhibitors | |
US2018305334A1 | Compounds, compositions and methods of use against stress granules | |
US2017088515A1 | Identification of compounds that disperse tdp-43 inclusions | |
US2017369474A1 | Compounds, compositions and methods of use | |
US2017360726A1 | Compounds, compositions and methods of use |